Study of HS-10382 Combination in Patients With Chronic Myeloid Leukemia (CML)

Clinical trial NCT06530810 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06530810
Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Myelogenous Leukemia CML Chronic Phase CML Accelerated Phase

Start date: 2024-07-31
Primary completion: 2026-05-08
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.